Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jong-Mu Sun

Showing results (31-40 of 303) with videos related to

Pageof 31
Sort By:
Lung Cancer (Amsterdam, Netherlands)|September 16, 2015
Pemetrexed plus platinum versus pemetrexed alone in non-small cell lung cancer patients who have progressed after first-line EGFR TKIsSu Jin Lee, Jong-Mu Sun, Se Hoon Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2017
Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung CancerSong Ee Park, Se Hoon Lee, Jin Seok Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2014
A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatinWon Jin Chang, Jong-Mu Sun, Ji Yean Lee, et al.
Thoracic Cancer|January 11, 2023
Adjuvant chemotherapy in node-positive patients after esophagectomy for esophageal squamous cell carcinomaYeong Jeong Jeon, Jong Ho Cho, Yong Soo Choi, et al.
Respiratory Medicine Case Reports|March 18, 2021
Second primary pleomorphic carcinoma arising from the pneumonectomy cavity of non-small cell lung cancer: A case reportChaiyoung Lee, Byeong-Ho Jeong, Kyungjong Lee, et al.
Cancer|March 23, 2022
Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinomaSehhoon Park, Dongryul Oh, Yoon-La Choi, et al.
Biology|October 10, 2020
Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, et al.
Cancer Research and Treatment|July 14, 2023
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World DataYoungkyung Jeon, Sehhoon Park, Hyun Ae Jung, et al.
Clinical Lung Cancer|January 27, 2019
Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase InhibitorJiyun Lee, Jong-Mu Sun, Se-Hoon Lee, et al.
Medical Oncology (Northwood, London, England)|July 23, 2016
Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasisSeonggyu Byeon, Jun Soo Ham, Jong-Mu Sun, et al.
Pageof 31

Showing results (31-40 of 303) with videos related to

Sort By:
Pageof 31
Lung Cancer (Amsterdam, Netherlands)|September 16, 2015
Pemetrexed plus platinum versus pemetrexed alone in non-small cell lung cancer patients who have progressed after first-line EGFR TKIsSu Jin Lee, Jong-Mu Sun, Se Hoon Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 5, 2017
Increased Response Rates to Salvage Chemotherapy Administered after PD-1/PD-L1 Inhibitors in Patients with Non-Small Cell Lung CancerSong Ee Park, Se Hoon Lee, Jin Seok Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|February 14, 2014
A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatinWon Jin Chang, Jong-Mu Sun, Ji Yean Lee, et al.
Thoracic Cancer|January 11, 2023
Adjuvant chemotherapy in node-positive patients after esophagectomy for esophageal squamous cell carcinomaYeong Jeong Jeon, Jong Ho Cho, Yong Soo Choi, et al.
Respiratory Medicine Case Reports|March 18, 2021
Second primary pleomorphic carcinoma arising from the pneumonectomy cavity of non-small cell lung cancer: A case reportChaiyoung Lee, Byeong-Ho Jeong, Kyungjong Lee, et al.
Cancer|March 23, 2022
Durvalumab and tremelimumab with definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinomaSehhoon Park, Dongryul Oh, Yoon-La Choi, et al.
Biology|October 10, 2020
Treatment and Outcomes of Metastatic Non-Small-Cell Lung Cancer Harboring Uncommon <i>EGFR</i> Mutations: Are They Different from Those with Common <i>EGFR</i> Mutations?Hyun Ae Jung, Sehhoon Park, Jong-Mu Sun, et al.
Cancer Research and Treatment|July 14, 2023
First-Line Alectinib vs. Brigatinib in Advanced Non-Small Cell Lung Cancer with ALK Rearrangement: Real-World DataYoungkyung Jeon, Sehhoon Park, Hyun Ae Jung, et al.
Clinical Lung Cancer|January 27, 2019
Efficacy and Safety of Lorlatinib in Korean Non-Small-Cell Lung Cancer Patients With ALK or ROS1 Rearrangement Whose Disease Failed to Respond to a Previous Tyrosine Kinase InhibitorJiyun Lee, Jong-Mu Sun, Se-Hoon Lee, et al.
Medical Oncology (Northwood, London, England)|July 23, 2016
Analysis of the benefit of sequential cranial radiotherapy in patients with EGFR mutant non-small cell lung cancer and brain metastasisSeonggyu Byeon, Jun Soo Ham, Jong-Mu Sun, et al.
Pageof 31